These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9642544)

  • 1. Neurological involvement in systemic lupus erythematosus.
    McLean BN
    Curr Opin Neurol; 1998 Jun; 11(3):247-51. PubMed ID: 9642544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central neuropsychiatric involvement in systemic lupus erythematosus].
    Madrane S; Ribi C
    Rev Med Suisse; 2012 Apr; 8(337):848-53. PubMed ID: 22594009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological Complications in Patients with Systemic Lupus Erythematosus.
    Shaban A; Leira EC
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):97. PubMed ID: 31773306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and autoantibodies in systemic lupus erythematosus.
    Hanly JG; Walsh NM; Fisk JD; Eastwood B; Hong C; Sherwood G; Jones JV; Jones E; Elkon K
    Br J Rheumatol; 1993 Apr; 32(4):291-6. PubMed ID: 8461922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
    Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
    Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.
    Kozora E; Erkan D; Zhang L; Zimmerman R; Ramon G; Ulug AM; Lockshin MD
    Clin Exp Rheumatol; 2014; 32(1):34-40. PubMed ID: 24021640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus.
    Teh LS; Hay EM; Amos N; Black D; Huddy A; Creed F; Bernstein RM; Holt PJ; Williams BD
    Br J Rheumatol; 1993 Apr; 32(4):287-90. PubMed ID: 8461921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.
    West SG; Emlen W; Wener MH; Kotzin BL
    Am J Med; 1995 Aug; 99(2):153-63. PubMed ID: 7625420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis.
    Press J; Palayew K; Laxer RM; Elkon K; Eddy A; Rakoff D; Silverman ED
    Arthritis Rheum; 1996 Apr; 39(4):671-6. PubMed ID: 8630119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-P antibodies and neuropsychiatric lupus erythematosus.
    Georgescu L; Mevorach D; Arnett FC; Reveille JD; Elkon KB
    Ann N Y Acad Sci; 1997 Aug; 823():263-9. PubMed ID: 9292053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus.
    Long AA; Denburg SD; Carbotte RM; Singal DP; Denburg JA
    Ann Rheum Dis; 1990 Apr; 49(4):249-53. PubMed ID: 2339907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
    Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).
    Asherson RA; Denburg SD; Denburg JA; Carbotte RM; Futrell N
    Postgrad Med J; 1993 Aug; 69(814):602-8. PubMed ID: 8234102
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease.
    Kozora E; Thompson LL; West SG; Kotzin BL
    Arthritis Rheum; 1996 Dec; 39(12):2035-45. PubMed ID: 8961909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobehavioural and psychiatric manifestations in a case of ANA-negative SLE with antiphospholipid antibodies.
    Zoli A; Altomonte L; Galossi A; Taranto A; Mirone L; Magaró M
    Clin Rheumatol; 1998; 17(1):68-70. PubMed ID: 9586684
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus.
    Toubi E; Khamashta MA; Panarra A; Hughes GR
    Am J Med; 1995 Oct; 99(4):397-401. PubMed ID: 7573096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.